Related Experiment Video
Updated: Jul 6, 2026

04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
Thyroidectomy for Graves' hyperthyroidism. Retrospective study of patients' appreciation
Nicola Palestini1, Manuela Grivon, Riccardo Durando
1General Surgery I Unit, Department of Medical and Surgical Sciences, University of Turin, Turin, Italy. npalestini@molinette.piemonte.it
Annali Italiani Di Chirurgia
|March 15, 2008
Summary
Surgery for Graves
Area of Science:
- Endocrinology
- Surgical Oncology
- Patient-Reported Outcomes
Background:
- Graves' hyperthyroidism is a common cause of hyperthyroidism.
- Surgical intervention is a treatment option for selected patients.
- Patient perspectives on surgical outcomes are crucial for evaluating treatment efficacy.
Purpose of the Study:
- To assess patient satisfaction and outcomes following surgical treatment for Graves' hyperthyroidism.
- To identify factors influencing patient views on thyroidectomy for Graves' disease.
Main Methods:
- Retrospective analysis of 102 patients undergoing thyroidectomy (subtotal or total) between 1993-2003.
- Data collected via questionnaires from 83 patients regarding preoperative, operative, and postoperative experiences.
Main Results:
- Significant improvements in quality of life (mean score 4.7 to 7.9) and working/studying ability (63%) post-surgery.
- High patient satisfaction with hospital efficiency (89%) and interpersonal care (96%).
- While most patients were satisfied, some reported voice changes (29%), scar dissatisfaction (11%), and worsening eye symptoms in a subset of patients with endocrine ophthalmopathy (60%).
Conclusions:
- Surgical treatment for Graves' hyperthyroidism is effective and meets the expectations of most patients.
- Patient-reported outcomes indicate overall positive experiences, though specific areas for improvement exist.
- Highlights the importance of managing expectations and addressing potential complications like voice changes and ophthalmopathy.
Related Concept Videos
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
